| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/01/2007 | EP1812052A1 Methods of cancer treatment/prevention using cancer cell-specific surface antigens |
| 08/01/2007 | EP1812051A2 Vlp-antigen conjugates and their uses as vaccines |
| 08/01/2007 | EP1812050A1 Composition comprising vlp and amyloid-beta peptide |
| 08/01/2007 | EP1812046A2 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 08/01/2007 | EP1812038A1 Fibronectin iii domain as leptin receptor antagonists |
| 08/01/2007 | EP1811838A2 Tweak as a therapeutic target for treating central nervous system diseases associated with cerebral edema and and cell death |
| 08/01/2007 | EP1636261B1 Thrombopoietin proteins with improved properties |
| 08/01/2007 | EP1294401B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 08/01/2007 | EP1214339B1 Polypeptides from moraxella (branhamella) catarrhalis |
| 08/01/2007 | EP1185615B1 Recombinant influenza viruses for vaccines and gene therapy |
| 08/01/2007 | EP1141293B1 Vascular endothelial growth factor-x |
| 08/01/2007 | EP1007537B1 Receptor protein designated 2f1 |
| 08/01/2007 | EP0986399B1 Chelating immunostimulating complexes |
| 08/01/2007 | EP0929310B1 Diagnostic and therapeutic methods related to regulating energy mobilization with ob protein and ob antibodies |
| 08/01/2007 | EP0695347B1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 08/01/2007 | CN1329513C Avian polynucleotide vaccine formula for anti pig's diseases |
| 08/01/2007 | CN1329512C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 08/01/2007 | CN1329413C Antibody for treating or preventing senile dementia, its expression vector and application in drug preparation |
| 08/01/2007 | CN1329082C Polymer conjugates of interferon beta-1a and their uses |
| 08/01/2007 | CN1329080C Cachexia remedy |
| 08/01/2007 | CN1329079C REV(reticuloendotheliosis virus) subunit vaccine and its production method |
| 08/01/2007 | CN101010427A Anti-A33 antibody |
| 08/01/2007 | CN101010342A Compositions and methods for treatment of non-hodgkin's lymphoma |
| 08/01/2007 | CN101010100A Treatment of cancer |
| 08/01/2007 | CN101010099A Edible vaccine |
| 08/01/2007 | CN101010098A Method for multiple sclerosis treatment and prophylaxis by therapy leptospira infecion |
| 08/01/2007 | CN101007851A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007849A Low molecule agonist antibodies |
| 08/01/2007 | CN101007844A Synthetic peptides and methods for treating cancer invasion and metastasis |
| 08/01/2007 | CN101007169A A microcapsule of egg yolk immunoglobulin, preparing process and use thereof |
| 08/01/2007 | CN101007168A SARS vaccine and its preparation method |
| 08/01/2007 | CN101007167A Mucosal meningococcal multivalence combined vaccines |
| 07/31/2007 | US7250506 Conjugated nucleotides to a detectable fluorescent dye; trancribing primers/probes for replication; qualitative and quantitative analysis of detecting viral nucleic acids |
| 07/31/2007 | US7250505 Polynucleotide that encodes the Drosophila murine Dab 1 (Disabled protein 1); improve the development of the nervous system; protein phosphotyrosine levels; Antibodies for drug screening and diagnostic methods |
| 07/31/2007 | US7250494 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
| 07/31/2007 | US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 07/31/2007 | US7250491 Hemolytic active proteins and genes encoding the same |
| 07/31/2007 | US7250489 Detecting nut allergy |
| 07/31/2007 | US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier |
| 07/31/2007 | US7250394 Blocking glutamate function at an ionotropic glutamate receptor. e.g., N-methyl-D-aspartate receptor, the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptor and the kainate receptor; brain disorders; spinal chord |
| 07/31/2007 | US7250286 Methods for the in vitro culture of Sporozoea sp. and uses thereof |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250279 Human pyruvate dehydrogenese phosphatase |
| 07/31/2007 | US7250276 Used to study cellular processes such as immune regulation, cell proliferation, cell death, and inflammatory responses |
| 07/31/2007 | US7250262 For the diagnosis and treatment of patients with disorders including anemias |
| 07/31/2007 | US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 07/31/2007 | US7250173 helminths obtained from preparatory animals raised in a specific human pathogen-free environment used to treat an excessive immune response including an aberrant/enhanced Th1 response, e.g., Crohn's disease and ulcerative colitis |
| 07/31/2007 | US7250172 Vaccine and compositions for the prevention and treatment of neisserial infections |
| 07/31/2007 | US7250170 Optimized expression of HPV 45 L1 in yeast |
| 07/31/2007 | US7250169 Anti-tumor activity of Ea-4-peptide of pro-IGF-1 |
| 07/31/2007 | US7250168 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome |
| 07/31/2007 | US7250167 Monoclonal antibody for use in increasing kidney allograft suvival and as immunosuppressant; prevention of graft versus host disease |
| 07/31/2007 | US7250166 human monoclonal antibodies against hepatiti c E1 antigen, reagent with such antibodies, vaccine; treating or preventing HCV infection by administration of the vaccine composition |
| 07/31/2007 | US7250165 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2007 | US7250164 Vaccine composition for preventing meningococcal disease |
| 07/31/2007 | US7250163 Preparing immunoglobulins specific to galanin binding protein for use in treatment and prevention of nervous system disorders |
| 07/31/2007 | US7250161 Equine GM-CSF |
| 07/31/2007 | CA2239596C Sugar-chain-recognizing antibodies and remedies for hiv infectious diseases |
| 07/31/2007 | CA2085469C Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons |
| 07/26/2007 | WO2007084856A2 Method for purifying polysaccharides |
| 07/26/2007 | WO2007084765A2 Injectable combination therapy for eye disorders |
| 07/26/2007 | WO2007084740A2 Tat-030 and methods of assessing and treating cancer |
| 07/26/2007 | WO2007084715A2 Tat-031 and methods of assessing and treating cancer |
| 07/26/2007 | WO2007084708A2 Tat-028 and methods of assessing and treating cancer |
| 07/26/2007 | WO2007084672A2 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues |
| 07/26/2007 | WO2007084599A2 Methods of increasing lymphatic function |
| 07/26/2007 | WO2007084388A2 Nogo-b receptor |
| 07/26/2007 | WO2007084253A2 High affinity antibodies against hmgb1 and methods of use thereof |
| 07/26/2007 | WO2007084181A2 Bispecific single chain fv antibody molecules and methods of use thereof |
| 07/26/2007 | WO2007084105A2 Modulation of fc gamma receptors for optimizing immunotherapy |
| 07/26/2007 | WO2007084053A1 A NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE) |
| 07/26/2007 | WO2007084021A2 Compositions and methods for diagnosing hiv-2 infection |
| 07/26/2007 | WO2007083807A1 Peptide derived from hepatitis c virus |
| 07/26/2007 | WO2007083806A1 HEPATITIS C VIRUS 2a-DERIVED HLA-A2-RESTRICTED ANTIGEN PEPTIDE |
| 07/26/2007 | WO2007083763A1 Method for production of emulsion preparation comprising physiologically active peptide, and kit for production of the preparation |
| 07/26/2007 | WO2007083759A1 Bone destruction inhibitor comprising anti-ccl20 antibody |
| 07/26/2007 | WO2007082899A1 Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration |
| 07/26/2007 | WO2007082352A1 Method of treatment, prophylaxis and diagnosis of pathologies of the bone |
| 07/26/2007 | WO2007065957A3 Methods for generating antigen-specific effector t cells |
| 07/26/2007 | WO2007064945A3 Cancer therapies and pharmaceutical compositions used therein |
| 07/26/2007 | WO2007056304A3 Mutated forms of ny-eso-1 produced in yeast and uses thereof |
| 07/26/2007 | WO2007042573A3 Compositions and methods for treating proliferative disorders |
| 07/26/2007 | WO2007041694A3 Compositions and methods for treating inflammation |
| 07/26/2007 | WO2007035455A3 Stabilizers for freeze-dried vaccines |
| 07/26/2007 | WO2007026078A3 T cd4+ epitopes of mage-a antigens restricted to hla-dp4 and the use thereof |
| 07/26/2007 | WO2007025166A3 Devices, compositions and methods for the protection and repair of cells and tissues |
| 07/26/2007 | WO2006133879A3 Vaccines for immunization against helicobacter |
| 07/26/2007 | WO2006132670A3 Auristatins having an aminobenzoic acid unit at the n terminus |
| 07/26/2007 | WO2006110745A3 Conjugated anti-psma antibodies |
| 07/26/2007 | WO2006084264A3 Cd20 antibody variants and uses thereof |
| 07/26/2007 | WO2006069036A3 Anti-il-12 antibodies, epitopes, compositions, methods and uses |
| 07/26/2007 | WO2005084158A3 Polypeptide transduction and fusogenic peptides |
| 07/26/2007 | WO2005051998A3 Antibodies binding to a c-terminal fragment of apolipoprotein e |
| 07/26/2007 | WO2003053220A3 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| 07/26/2007 | WO2002038600A9 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 07/26/2007 | US20070174923 Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS) |
| 07/26/2007 | US20070174922 Nucleic acid encoding novel type-1 cytokine receptor glm-r |
| 07/26/2007 | US20070173525 Receptor or non-receptor types; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, agents; retinal vascularization |
| 07/26/2007 | US20070173469 Administering immunomer comprising at least two oligonucleotides linked at their 3' ends, internucleoside linkages or functionalized nucleobase or sugar to a nonnucleotidic linker, at least one oligonucleotide an immunostimulant having accessible 5' end |